XOMA Royalty Corp
XOMA34.200USD
+1.450+4.43%
Handelsschluss 08/22, 16:00（ET）Kurse um 15 Minuten verzögert
412.54MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über XOMA Royalty Corp Unternehmen
XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to larger pharmaceutical partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's royalty portfolio includes OJEMDA (tovorafenib), JNJ-63723283 (cetrelimab), RZ358, arimoclomol, mezagitamab (TAK-079), acimtamig (AFM13), AB054, ficlatuzumab (AV-299), COM902, vosaroxin, aldoxorubicin, INCAGN02385, INCAGN02390, MNPR-101, PBF-680, PBF-677, PBF-999, PBF-1129, PBF-1650, RZ402, DSUVIA (sufentanil sublingual tablet), IXINITY [coagulation factor IX (recombinant)], CMP-001 (vidutolimod), NTM-1631, NTM-1634, NTM-1633, NTM-1632, NIR178, MK-4830, AFM24, INCAGN01949, AB101, and CFZ533 (iscalimab).
Unternehmensinformationen
BörsenkürzelXOMA
Name des UnternehmensXOMA Royalty Corp
IPO-datumJun 06, 1986
CEOMr. Owen P. Hughes, Jr.
Anzahl der mitarbeiter13
WertpapierartOrdinary Share
GeschäftsjahresendeJun 06
Addresse2200 Powell Street
StadtEMERYVILLE
BörseNASDAQ Global Market Consolidated
LandUnited States of America
Postleitzahl94608
Telefon15102047239
Websitehttps://www.xoma.com/
BörsenkürzelXOMA
IPO-datumJun 06, 1986
CEOMr. Owen P. Hughes, Jr.
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jack L. Wyszomierski
Mr. Jack L. Wyszomierski
Independent Chairman of the Board
Independent Chairman of the Board
12.44K
+92.36%
Mr. Joseph M. (Joe) Limber
Mr. Joseph M. (Joe) Limber
Independent Director
Independent Director
6.21K
-0.03%
Ms. Natasha A. Hernday
Ms. Natasha A. Hernday
Independent Director
Independent Director
5.97K
--
Ms. Heather L. Franklin
Ms. Heather L. Franklin
Independent Director
Independent Director
5.97K
--
Mr. Thomas (Tom) Burns
Mr. Thomas (Tom) Burns
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Ms. Barbara A. Kosacz, J.D.
Ms. Barbara A. Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Matthew D. Perry
Mr. Matthew D. Perry
Independent Director
Independent Director
--
--
Mr. Owen P. Hughes, Jr.
Mr. Owen P. Hughes, Jr.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Bradley J. (Brad) Sitko
Mr. Bradley J. (Brad) Sitko
Chief Investment Officer
Chief Investment Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jack L. Wyszomierski
Mr. Jack L. Wyszomierski
Independent Chairman of the Board
Independent Chairman of the Board
12.44K
+92.36%
Mr. Joseph M. (Joe) Limber
Mr. Joseph M. (Joe) Limber
Independent Director
Independent Director
6.21K
-0.03%
Ms. Natasha A. Hernday
Ms. Natasha A. Hernday
Independent Director
Independent Director
5.97K
--
Ms. Heather L. Franklin
Ms. Heather L. Franklin
Independent Director
Independent Director
5.97K
--
Mr. Thomas (Tom) Burns
Mr. Thomas (Tom) Burns
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Ms. Barbara A. Kosacz, J.D.
Ms. Barbara A. Kosacz, J.D.
Independent Director
Independent Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
6.09M
38.30%
Switzerland
5.82M
36.56%
Asia Pacific
4.00M
25.14%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Fri, Aug 15
Aktualisiert: Fri, Aug 15
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BVF Partners L.P.
21.43%
Morgan Stanley Investment Management Inc. (US)
12.61%
Fidelity Management & Research Company LLC
8.59%
The Vanguard Group, Inc.
5.28%
BlackRock Institutional Trust Company, N.A.
4.47%
Andere
47.61%
Aktionäre
Aktionäre
Anteil
BVF Partners L.P.
21.43%
Morgan Stanley Investment Management Inc. (US)
12.61%
Fidelity Management & Research Company LLC
8.59%
The Vanguard Group, Inc.
5.28%
BlackRock Institutional Trust Company, N.A.
4.47%
Andere
47.61%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
25.40%
Investment Advisor
23.03%
Investment Advisor/Hedge Fund
19.18%
Individual Investor
1.32%
Research Firm
0.23%
Pension Fund
0.08%
Bank and Trust
0.08%
Insurance Company
0.03%
Andere
30.64%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
147
7.87M
65.79%
+337.12K
2025Q1
150
7.99M
66.81%
+297.02K
2024Q4
151
7.96M
67.53%
-445.61K
2024Q3
149
7.79M
66.29%
-572.80K
2024Q2
143
7.78M
66.74%
-664.29K
2024Q1
144
7.71M
66.30%
-615.38K
2023Q4
149
7.62M
66.29%
-820.22K
2023Q3
146
7.80M
68.02%
-670.64K
2023Q2
148
7.93M
69.11%
+32.68K
2023Q1
155
7.51M
65.57%
+97.45K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BVF Partners L.P.
2.59M
21.65%
-392.72K
-13.17%
May 16, 2025
Morgan Stanley Investment Management Inc. (US)
1.10M
9.23%
+811.40K
+277.18%
Mar 31, 2025
Fidelity Management & Research Company LLC
1.04M
8.68%
-1.68K
-0.16%
Mar 31, 2025
The Vanguard Group, Inc.
459.09K
3.84%
-4.75K
-1.02%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
490.59K
4.1%
-8.20K
-1.64%
Mar 31, 2025
Opaleye Management Inc.
253.04K
2.11%
+3.04K
+1.22%
Mar 31, 2025
Geode Capital Management, L.L.C.
186.67K
1.56%
+4.48K
+2.46%
Mar 31, 2025
Woodline Partners LP
168.55K
1.41%
+12.28K
+7.86%
Mar 31, 2025
State Street Global Advisors (US)
144.73K
1.21%
+200.00
+0.14%
Mar 31, 2025
Stonepine Capital Management, LLC
129.81K
1.08%
+4.11K
+3.27%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Wed, Aug 6
Aktualisiert: Wed, Aug 6
Name
Anteil
iShares Micro-Cap ETF
0.05%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Avantis US Equity ETF
0%
Mehr Anzeigen
iShares Micro-Cap ETF
Anteil0.05%
Invesco Russell 2000 Dynamic Multifactor ETF
Anteil0.01%
ProShares Hedge Replication ETF
Anteil0.01%
iShares Russell 2000 ETF
Anteil0.01%
iShares Russell 2000 Growth ETF
Anteil0.01%
iShares Russell 2000 Value ETF
Anteil0.01%
ProShares UltraPro Russell2000
Anteil0.01%
Global X Russell 2000 ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%
Avantis US Equity ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
